Toshiharu Kondo

501 total citations
20 papers, 420 citations indexed

About

Toshiharu Kondo is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Toshiharu Kondo has authored 20 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Cell Biology. Recurrent topics in Toshiharu Kondo's work include Protease and Inhibitor Mechanisms (6 papers), NF-κB Signaling Pathways (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Toshiharu Kondo is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), NF-κB Signaling Pathways (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Toshiharu Kondo collaborates with scholars based in Japan and United States. Toshiharu Kondo's co-authors include Tatsuo Yagyu, Kiyokazu Inagaki, Hiroshi Kobayashi, Toshihiko Terao, Naohiro Kanayama, Mika Suzuki, Noriyuki Kurita, Hideo Sekino, Ryuji Yoshida and Hidenori Matsuzaki and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Toshiharu Kondo

19 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshiharu Kondo Japan 13 180 71 66 64 60 20 420
Kiyokazu Inagaki Japan 13 175 1.0× 71 1.0× 66 1.0× 63 1.0× 60 1.0× 17 410
Tatsuo Yagyu Japan 13 200 1.1× 74 1.0× 69 1.0× 85 1.3× 65 1.1× 21 480
Arthur Brouillet France 18 295 1.6× 79 1.1× 71 1.1× 199 3.1× 58 1.0× 23 723
Pantipa Subhasitanont Thailand 13 289 1.6× 75 1.1× 21 0.3× 45 0.7× 43 0.7× 18 531
Haydar Çelik United States 13 232 1.3× 48 0.7× 18 0.3× 56 0.9× 38 0.6× 27 447
Keiko Shoji Japan 10 361 2.0× 70 1.0× 15 0.2× 48 0.8× 17 0.3× 20 657
Ching Liao Sweden 8 250 1.4× 45 0.6× 64 1.0× 22 0.3× 51 0.8× 10 385
Margalit Krup Israel 8 177 1.0× 32 0.5× 16 0.2× 117 1.8× 35 0.6× 11 483
Tao Xin China 16 277 1.5× 91 1.3× 45 0.7× 41 0.6× 47 0.8× 40 622
Salma Awad United States 16 593 3.3× 48 0.7× 45 0.7× 28 0.4× 67 1.1× 20 805

Countries citing papers authored by Toshiharu Kondo

Since Specialization
Citations

This map shows the geographic impact of Toshiharu Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiharu Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiharu Kondo more than expected).

Fields of papers citing papers by Toshiharu Kondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiharu Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiharu Kondo. The network helps show where Toshiharu Kondo may publish in the future.

Co-authorship network of co-authors of Toshiharu Kondo

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiharu Kondo. A scholar is included among the top collaborators of Toshiharu Kondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiharu Kondo. Toshiharu Kondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomoda, Keisuke, Naoko Takahashi, Yurina Hibi, et al.. (2008). Molecular docking analysis of the protein–protein interaction between RelA‐associated inhibitor and tumor suppressor protein p53 and its inhibitory effect on p53 action. Cancer Science. 99(3). 615–622. 5 indexed citations
2.
Kobayashi, Hiroshi, Ryuji Yoshida, Tatsuo Yagyu, et al.. (2005). DIETARY SUPPLEMENTATION OF SOYBEAN KUNITZ TRYPSIN INHIBITOR REDUCES LIPOPOLYSACCHARIDE-INDUCED LETHALITY IN MOUSE MODEL. Shock. 23(5). 441–447. 8 indexed citations
3.
Kobayashi, Hiroshi, Ryuji Yoshida, Tatsuo Yagyu, et al.. (2005). Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model. Journal of Cancer Research and Clinical Oncology. 131(8). 527–538. 95 indexed citations
4.
Kobayashi, Hiroshi, Ryuji Yoshida, Tatsuo Yagyu, et al.. (2005). Suppression of lipopolysaccharide‐induced cytokine production of gingival fibroblasts by a soybean, Kunitz trypsin inhibitor. Journal of Periodontal Research. 40(6). 461–468. 17 indexed citations
5.
Inagaki, Kiyokazu, Hiroshi Kobayashi, Ryuji Yoshida, et al.. (2005). Suppression of Urokinase Expression and Invasion by a Soybean Kunitz Trypsin Inhibitor Are Mediated through Inhibition of Src-dependent Signaling Pathways. Journal of Biological Chemistry. 280(36). 31428–31437. 12 indexed citations
6.
Kobayashi, Hiroshi, Ryuji Yoshida, Tatsuo Yagyu, et al.. (2005). A soybean Kunitz trypsin inhibitor reduces tumor necrosis factor‐α production in ultraviolet‐exposed primary human keratinocytes. Experimental Dermatology. 14(10). 765–774. 7 indexed citations
7.
Yagyu, Tatsuo, Hiroshi Kobayashi, Toshiharu Kondo, et al.. (2005). Enhanced spontaneous metastasis in bikunin‐deficient mice. International Journal of Cancer. 118(9). 2322–2328. 15 indexed citations
8.
Kobayashi, Hiroshi, Tatsuo Yagyu, Hidenori Matsuzaki, et al.. (2005). Bikunin Suppresses Lipopolysaccharide‐Induced Lethality through Down‐Regulation of Tumor Necrosis Factor–α and Interleukin‐1β in Macrophages. The Journal of Infectious Diseases. 191(6). 930–938. 35 indexed citations
9.
Kobayashi, Hiroshi, Tatsuo Yagyu, Toshiharu Kondo, et al.. (2005). Suppression of Urokinase Receptor Expression by Thalidomide Is Associated with Inhibition of Nuclear Factor κB Activation and Subsequently Suppressed Ovarian Cancer Dissemination. Cancer Research. 65(22). 10464–10471. 15 indexed citations
10.
Yagyu, Tatsuo, Hiroshi Kobayashi, Toshiharu Kondo, et al.. (2005). Thalidomide Inhibits Tumor Necrosis Factor-α-Induced Interleukin-8 Expression in Endometriotic Stromal Cells, Possibly through Suppression of Nuclear Factor-κB Activation. The Journal of Clinical Endocrinology & Metabolism. 90(5). 3017–3021. 54 indexed citations
11.
Matsuzaki, Hidenori, Hiroshi Kobayashi, Tatsuo Yagyu, et al.. (2005). Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism. Oncology Reports. 14(2). 449–57. 9 indexed citations
12.
Kobayashi, Hiroshi, Tatsuo Yagyu, Toshiharu Kondo, et al.. (2005). Plasma Bikunin As a Favorable Prognostic Factor in Ovarian Cancer. Journal of Clinical Oncology. 23(7). 1463–1472. 34 indexed citations
13.
Yagyu, Tatsuo, Hiroshi Kobayashi, Hidenori Matsuzaki, et al.. (2004). A kunitz‐type protease inhibitor bikunin disrupts ligand‐induced oligomerization of receptors for transforming growth factor (TGF)‐β and subsequently suppresses TGF‐β signalings. FEBS Letters. 576(3). 408–416. 8 indexed citations
14.
Kobayashi, Hiroshi, Tatsuo Yagyu, Hidenori Matsuzaki, et al.. (2004). Transforming growth factor‐β1‐dependent activation of Smad2/3 and up‐regulation of PAI‐1 expression is negatively regulated by Src in SKOV‐3 human ovarian cancer cells. Journal of Cellular Biochemistry. 93(3). 437–453. 12 indexed citations
15.
Kobayashi, Hiroshi, Tatsuo Yagyu, Kiyokazu Inagaki, et al.. (2004). Therapeutic efficacy of once‐daily oral administration of a Kunitz‐type protease inhibitor, bikunin, in a mouse model and in human cancer. Cancer. 100(4). 869–877. 31 indexed citations
16.
Kobayashi, Hiroshi, Tatsuo Yagyu, Hidenori Matsuzaki, et al.. (2004). Bikunin down‐regulates heterodimerization between CD44 and growth factor receptors and subsequently suppresses agonist‐mediated signaling. Journal of Cellular Biochemistry. 94(5). 995–1009. 17 indexed citations
17.
Kobayashi, Hiroshi, Tatsuo Yagyu, Kiyokazu Inagaki, et al.. (2004). Bikunin plus paclitaxel markedly reduces tumor burden and ascites in mouse model of ovarian cancer. International Journal of Cancer. 110(1). 134–139. 17 indexed citations
18.
Matsuzaki, Hidenori, Hiroshi Kobayashi, Tatsuo Yagyu, et al.. (2004). Bikunin Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Induction in Macrophages. Clinical and Vaccine Immunology. 11(6). 1140–1147. 24 indexed citations
19.
Ohshima, Tohru, Naofumi Mukaida, Yuji Ishida, Toshiharu Kondo, & Ryoichi Mori. (2001). Accelerated wound healing in TNF receptor p55 deficient mice with reduced leukocyte infiltration. Journal of Leukocyte Biology. 50. 3 indexed citations
20.
Kondo, Toshiharu, et al.. (1999). Numerical Simulation of Aeroacoustic Sources in the Flow around Rectangular Cross-Sections. Journal of Applied Mechanics. 2. 573–581. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026